Bank of New York Mellon Corp - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 50 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2019$1,030,000
+0.4%
900,0000.0%0.00%
Q3 2019$1,026,000
-3.9%
900,0000.0%0.00%
Q2 2019$1,068,000
-12.2%
900,0000.0%0.00%
Q1 2019$1,217,000
+182.4%
900,000
+125.0%
0.00%
Q4 2018$431,000
-54.5%
400,000
-55.6%
0.00%
Q3 2018$947,000
+7.4%
900,0000.0%0.00%
Q2 2018$882,000
-25.9%
900,000
-25.0%
0.00%
Q1 2018$1,190,000
-6.0%
1,200,0000.0%0.00%
Q4 2017$1,266,000
-0.5%
1,200,0000.0%0.00%
Q3 2017$1,273,000
+0.1%
1,200,0000.0%0.00%
Q2 2017$1,272,000
+10.2%
1,200,0000.0%0.00%
Q1 2017$1,154,000
-17.3%
1,200,000
-11.1%
0.00%
Q4 2016$1,395,000
+232.1%
1,350,000
+200.0%
0.00%
Q3 2016$420,000
+32.5%
450,0000.0%0.00%
Q2 2016$317,000
-65.2%
450,000
-55.0%
0.00%
Q1 2016$910,000
-18.0%
1,000,0000.0%0.00%
Q4 2015$1,110,0001,000,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2020
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 17,307,000$17,094,989,0002.72%
STEELHEAD PARTNERS LLC 30,000,000$29,745,0002.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 25,097,000$25,027,0001.58%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$45,283,0001.57%
Jabre Capital Partners S.A. 4,500,000$4,458,0000.96%
ADVENT CAPITAL MANAGEMENT /DE/ 48,598,000$48,198,0000.95%
SSI INVESTMENT MANAGEMENT LLC 11,606,000$11,468,0000.93%
Verition Fund Management LLC 10,025,000$9,942,0000.74%
LINDEN ADVISORS LP 31,259,000$30,992,0000.74%
WOLVERINE ASSET MANAGEMENT LLC 42,644,000$42,343,0000.55%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders